PubMed · 1993 · 117 citations · 33 references
MedicineCancer BiologyOncologyCell SignalingMolecular OncologySignal TransductionHormonal TherapyMammary Epithelial Cell BiologyMammary TumorsEstrogen PharmacologyEstrogen Receptor SignalingGrowth Inhibition AssaysHormone Receptor - Positive Breast Cancer
Estrogen is essential for the growth of the normal mammary gland and most estrogen receptor (ER)-positive mammary carcinomas. To better understand the differences between the estrogen response pathways in normal and tumor cells, we have stably transfected ER-negative immortal, nontumorigenic human mammary epithelial cells and ER-negative breast cancer cells with an ER-encoding expression vector. Unexpectedly, estrogen treatment (1.0 nM) inhibited the proliferation of ER-transfected nontumorigenic and tumor-derived cells. The control transfectants and parental cells exhibited no response to estrogen concentrations as high as 1.0 microM. This inhibitory effect was attributed to a decreased growth rate and a perturbation of the cell cycle distribution by estrogen treatment of the ER transfectants. The inhibitory response was blocked by cotreatment with the antiestrogen ICI 164,384 as predicted for a pure antagonist of estrogen action. However, treatment with the antiestrogen hydroxytamoxifen caused growth inhibition, implying that hydroxytamoxifen acts as an agonist of estrogen action in ER-transfected cells. Since estrogen is a mitogenic and not a growth-inhibitory stimulus for ER-positive breast cancers and cell lines, we tested the effect of constitutive, high level expression of the ER in ER-positive tumor cells. Stable transfection of ER-positive MCF-7 and T47D cells with the ER expression vector yielded cells with varying amounts of ER. At ER levels comparable to those found in the ER-negative transfected cells, the MCF-7 and T47D ER transfectants were not inhibited by estrogen. These data suggest that ER-positive breast cancer cells can tolerate higher constitutive levels of ER expression than ER-negative cells. The mechanism by which this is accomplished may be an essential step in the process which yields ER-positive tumors.
33
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
Stephen Green, Philippe Walter, Vijay Kumar et al. · Nature · 1986 · 2.3K citations
Steroid hormone receptors compete for factors that mediate their enhancer function
Marc-Étienne Meyer, Hinrich Gronemeyer, Bernard Turcotte et al. · Cell · 1989 · 582 citations
Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex
Marie‐Pierre Gaub, María Elena de Bellard, I Scheuer et al. · Cell · 1990 · 483 citations
Immunochemical studies of estrogen receptors
Geoffrey L. Greene, Nancy B. Sobel, William King et al. · Journal of Steroid Biochemistry · 1984 · 439 citations